18,611 results on '"Brian P. An"'
Search Results
2. The benefits of meeting buyer privacy expectations across information, time, and space dimensions
- Author
-
Kunal Swani, George R. Milne, and Brian P. Brown
- Subjects
Marketing - Published
- 2023
3. Novel Arthrometer for Quantifying In Vivo Knee Laxity in Three Planes Following Total Knee Arthroplasty
- Author
-
David Z. Shamritsky, Erin E. Berube, Nicolas Sapountzis, Allison Diaz, Ethan C. Krell, Timothy M. Wright, Michael Parides, Geoffrey H. Westrich, David J. Mayman, Peter K. Sculco, Brian P. Chalmers, and Carl W. Imhauser
- Subjects
Orthopedics and Sports Medicine - Published
- 2023
4. Significantly Worse Fixation of Cemented Patellar Components on Multiacquisition Variable-Resonance Image Combination Magnetic Resonance Imaging Compared to Femoral and Tibial Components: A Cause for Concern?
- Author
-
Eytan M. Debbi, David J. Mayman, Nicolas Sapountzis, Joseph Hawes, Agnes D. Cororaton, Hollis G. Potter, Steven B. Haas, and Brian P. Chalmers
- Subjects
Orthopedics and Sports Medicine - Published
- 2023
5. No Difference in the Rate of Periprosthetic Joint Infection in Patients Undergoing the Posterolateral Compared to the Direct Anterior Approach
- Author
-
Brian P. Chalmers, Simarjeet Puri, Adam Watkins, Agnes D. Cororaton, Andy O. Miller, Alberto V. Carli, and Michael M. Alexiades
- Subjects
Orthopedics and Sports Medicine - Published
- 2023
6. Primary and Revision Total Hip Arthroplasty in Patients With Pulmonary Hypertension: High Perioperative Mortality and Medical Complications
- Author
-
Courtney E. Baker, Brian P. Chalmers, Michael J. Taunton, Adam W. Amundson, Daniel J. Berry, and Matthew P. Abdel
- Subjects
Orthopedics and Sports Medicine - Abstract
Perioperative medical management during total hip arthroplasty (THA) is continuously improving, allowing an increasing number of medically complex patients to undergo total joint arthroplasty. This study examined mortalities, medical complications, implant survivorships, and clinical outcomes of THA in patients who have pulmonary hypertension (HTN).We identified 638 patients who had pulmonary HTN and underwent 508 primary THAs and 191 revision THAs from 2000 to 2016 at a tertiary care center. Patients were followed up at regular intervals until death, revision surgery, or last clinical follow-up. Perioperative medical complications were individually reviewed. The risk of death was examined by calculating standardized mortality ratios and Cox proportional hazards regression models. Cumulative incidence analyses were used for reporting mortality, reoperation, and revision with death as a competing risk.The 90-day mortality was 1.8 and 3.1% for primary and revision THAs, respectively. The risk of death was approximately two-fold higher compared to primary (HR 2.69) and revision (HR 2.04) THA patients who did not have pulmonary HTN. Rate of medical complications within 90 days from surgery were 6.2 and 13.1% in primary and revision THAs, respectively. The 10-year cumulative incidence of any revision was 9 and 14% following primaries and revisions, respectively.Patients who had pulmonary HTN undergoing primary and revision THAs had increased risk of death and experienced a high rate of medical complications within 90 days of surgery. Counseling of risks, medical optimization, and referral to medical centers expert at managing complex medical problems should be considered.
- Published
- 2023
7. Lake Ontario’s nearshore zooplankton: Community composition changes and comparisons to the offshore
- Author
-
Stephanie E. Figary, Kristen T. Holeck, Christopher W. Hotaling, James M. Watkins, Jana R. Lantry, Michael J. Connerton, Scott E. Prindle, Zy F. Biesinger, Brian P. O'Malley, and Lars G. Rudstam
- Subjects
Ecology ,Aquatic Science ,Ecology, Evolution, Behavior and Systematics - Published
- 2023
8. Micro-Transfer Printing for Heterogeneous Integration of GaN and GaAs HEMTs
- Author
-
Brian P. Downey, Shawn Mack, Andy Xie, D. Scott Katzer, Andrew C. Lang, James G. Champlain, Yu Cao, Neeraj Nepal, Tyler A. Growden, Vikrant J. Gokhale, Matthew T. Hardy, Edward Beam, Cathy Lee, and David J. Meyer
- Subjects
Electrical and Electronic Engineering ,Electronic, Optical and Magnetic Materials - Published
- 2023
9. Phase 3 Trial of Epicutaneous Immunotherapy in Toddlers with Peanut Allergy
- Author
-
Matthew Greenhawt, Sayantani B. Sindher, Julie Wang, Michael O’Sullivan, George du Toit, Edwin H. Kim, Deborah Albright, Sara Anvari, Nicolette Arends, Peter D. Arkwright, Philippe Bégin, Katharina Blumchen, Thierry Bourrier, Terri Brown-Whitehorn, Heather Cassell, Edmond S. Chan, Christina E. Ciaccio, Antoine Deschildre, Amandine Divaret-Chauveau, Stacy L. Dorris, Morna J. Dorsey, Thomas Eiwegger, Michel Erlewyn-Lajeunesse, David M. Fleischer, Lara S. Ford, Maria Garcia-Lloret, Lisa Giovannini-Chami, Jonathan O. Hourihane, Nicola Jay, Stacie M. Jones, Leigh Ann Kerns, Kirsten M. Kloepfer, Stephanie Leonard, Guillaume Lezmi, Jay A. Lieberman, Jeanne Lomas, Melanie Makhija, Christopher Parrish, Jane Peake, Kirsten P. Perrett, Daniel Petroni, Wolfgang Pfützner, Jacqueline A. Pongracic, Patrick Quinn, Rachel G. Robison, Georgiana Sanders, Lynda Schneider, Hemant P. Sharma, Juan Trujillo, Paul J. Turner, Katherine Tuttle, Julia E. Upton, Pooja Varshney, Brian P. Vickery, Christian Vogelberg, Brynn Wainstein, Robert A. Wood, Katharine J. Bee, Dianne E. Campbell, Todd D. Green, Rihab Rouissi, Aurélie Peillon, Henry T. Bahnson, Timothée Bois, Hugh A. Sampson, A. Wesley Burks, and Pediatrics
- Subjects
General Medicine - Abstract
Background No approved treatment for peanut allergy exists for children younger than 4 years of age, and the efficacy and safety of epicutaneous immunotherapy with a peanut patch in toddlers with peanut allergy are unknown. Methods We conducted this phase 3, multicenter, double-blind, randomized, placebo-controlled trial involving children 1 to 3 years of age with peanut allergy confirmed by a double-blind, placebo-controlled food challenge. Patients who had an eliciting dose (the dose necessary to elicit an allergic reaction) of 300 mg or less of peanut protein were assigned in a 2:1 ratio to receive epicutaneous immunotherapy delivered by means of a peanut patch (intervention group) or to receive placebo administered daily for 12 months. The primary end point was a treatment response as measured by the eliciting dose of peanut protein at 12 months. Safety was assessed according to the occurrence of adverse events during the use of the peanut patch or placebo. Results Of the 362 patients who underwent randomization, 84.8% completed the trial. The primary efficacy end point result was observed in 67.0% of children in the intervention group as compared with 33.5% of those in the placebo group (risk difference, 33.4 percentage points; 95% confidence interval, 22.4 to 44.5; P
- Published
- 2023
10. Pirtobrutinib targets BTK C481S in ibrutinib-resistant CLL but second-site BTK mutations lead to resistance
- Author
-
Aishath Naeem, Filippo Utro, Qing Wang, Justin Cha, Mauno Vihinen, Stephen Martindale, Yinglu Zhou, Yue Ren, Svitlana Tyekucheva, Annette S. Kim, Stacey M. Fernandes, Gordon Saksena, Kahn Rhrissorrakrai, Chaya Levovitz, Brian P. Danysh, Kara Slowik, Raquel A. Jacobs, Matthew S. Davids, James A. Lederer, Rula Zain, C. I. Edvard Smith, Ignaty Leshchiner, Laxmi Parida, Gad Getz, and Jennifer R. Brown
- Subjects
Hematology - Abstract
Covalent inhibitors of Bruton tyrosine kinase (BTK) have transformed the therapy of chronic lymphocytic leukemia (CLL), but continuous therapy has been complicated by the development of resistance. The most common resistance mechanism in patients whose disease progresses on covalent BTK inhibitors (BTKis) is a mutation in the BTK 481 cysteine residue to which the inhibitors bind covalently. Pirtobrutinib is a highly selective, noncovalent BTKi with substantial clinical activity in patients whose disease has progressed on covalent BTKi, regardless of BTK mutation status. Using in vitro ibrutinib-resistant models and cells from patients with CLL, we show that pirtobrutinib potently inhibits BTK-mediated functions including B-cell receptor (BCR) signaling, cell viability, and CCL3/CCL4 chemokine production in both BTK wild-type and C481S mutant CLL cells. We demonstrate that primary CLL cells from responding patients on the pirtobrutinib trial show reduced BCR signaling, cell survival, and CCL3/CCL4 chemokine secretion. At time of progression, these primary CLL cells show increasing resistance to pirtobrutinib in signaling inhibition, cell viability, and cytokine production. We employed longitudinal whole-exome sequencing on 2 patients whose disease progressed on pirtobrutinib and identified selection of alternative-site BTK mutations, providing clinical evidence that secondary BTK mutations lead to resistance to noncovalent BTKis.
- Published
- 2023
11. Sustained release hydrogel for durable locoregional chemoimmunotherapy for BRAF-mutated melanoma
- Author
-
Jihoon Kim, Paul A. Archer, Margaret P. Manspeaker, Alexa R.C. Avecilla, Brian P. Pollack, and Susan N. Thomas
- Subjects
Pharmaceutical Science - Published
- 2023
12. Implant cost variation in surgically treated distal radius fractures
- Author
-
Stephen A. Doxey, Fernando A. Huyke-Hernández, Jennifer L. Robb, Deborah C. Bohn, and Brian P. Cunningham
- Subjects
Orthopedics and Sports Medicine - Published
- 2023
13. Comprehensive Phenotypic Characterization of Late Gadolinium Enhancement Predicts Sudden Cardiac Death in Coronary Artery Disease
- Author
-
Richard E. Jones, Hassan A. Zaidi, Daniel J. Hammersley, Suzan Hatipoglu, Ruth Owen, Gabriel Balaban, Antonio de Marvao, François Simard, Amrit S. Lota, Ciara Mahon, Batool Almogheer, Lukas Mach, Francesca Musella, Xiuyu Chen, John Gregson, Laura Lazzari, Andrew Ravendren, Francisco Leyva, Shihua Zhao, Ali Vazir, Pablo Lamata, Brian P. Halliday, Dudley J. Pennell, Martin J. Bishop, and Sanjay K. Prasad
- Subjects
Radiology, Nuclear Medicine and imaging ,Cardiology and Cardiovascular Medicine - Abstract
Background Late gadolinium enhancement (LGE) cardiac magnetic resonance (CMR) offers the potential to noninvasively characterize the phenotypic substrate for sudden cardiac death (SCD). Objectives The authors assessed the utility of infarct characterization by CMR, including scar microstructure analysis, to predict SCD in patients with coronary artery disease (CAD). Methods Patients with stable CAD were prospectively recruited into a CMR registry. LGE quantification of core infarction and the peri-infarct zone (PIZ) was performed alongside computational image analysis to extract morphologic and texture scar microstructure features. The primary outcome was SCD or aborted SCD. Results Of 437 patients (mean age: 64 years; mean left ventricular ejection fraction [LVEF]: 47%) followed for a median of 6.3 years, 49 patients (11.2%) experienced the primary outcome. On multivariable analysis, PIZ mass and core infarct mass were independently associated with the primary outcome (per gram: HR: 1.07 [95% CI: 1.02-1.12]; P = 0.002 and HR: 1.03 [95% CI: 1.01-1.05]; P = 0.01, respectively), and the addition of both parameters improved discrimination of the model (Harrell’s C-statistic: 0.64-0.79). PIZ mass, however, did not provide incremental prognostic value over core infarct mass based on Harrell’s C-statistic or risk reclassification analysis. Severely reduced LVEF did not predict the primary endpoint after adjustment for scar mass. On scar microstructure analysis, the number of LGE islands in addition to scar transmurality, radiality, interface area, and entropy were all associated with the primary outcome after adjustment for severely reduced LVEF and New York Heart Association functional class of >1. No scar microstructure feature remained associated with the primary endpoint when PIZ mass and core infarct mass were added to the regression models. Conclusions Comprehensive LGE characterization independently predicted SCD risk beyond conventional predictors used in implantable cardioverter-defibrillator (ICD) insertion guidelines. These results signify the potential for a more personalized approach to determining ICD candidacy in CAD.
- Published
- 2023
14. Analysis of dermatologic procedures billed independently by nonphysician practitioners in the United States
- Author
-
Brett M. Coldiron, Qiaochu Qi, Brian P. Hibler, and Anthony M. Rossi
- Subjects
Dermatologic Procedures ,medicine.medical_specialty ,Scope of practice ,Scope (project management) ,Nurse practitioners ,business.industry ,Retrospective cohort study ,Dermatology ,Primary care ,Durable medical equipment ,030207 dermatology & venereal diseases ,03 medical and health sciences ,0302 clinical medicine ,Master file ,030220 oncology & carcinogenesis ,Family medicine ,medicine ,business ,health care economics and organizations - Abstract
Background Non-physician practitioners (NPPS), including nurse practitioners (NPs) and physician assistants (PAs) are expanding their scope of practice outside of primary care and performing more procedures in dermatology. Objective To understand the scope and geographic pattern of practice by NPs and PAs in dermatology in the US. Methods Cross-sectional retrospective cohort analysis of dermatology practices in the 2014 Medicare Physician/Supplier Procedure Summary Master File, which reflects Part B carrier and durable medical equipment fee-for-service claims in the US. Results Over 4 million procedures were billed independently by NPs and PAs, which accounts for 11.51% of all. Injection, simple repair, and biopsy were the most commonly billed by non-physician practitioners, but complex procedures were also increasingly billed independently by NPs and PAs. Proportions of their claims are higher in the East Coast, Midwest, and Mountain states. Limitations Data is at the state level, limited to Medicare beneficiaries, and doesn’t include billing incident-to physicians. Conclusions This study demonstrated the increasing scope of practice of NPs and PAs in dermatology, despite limited training and lack of uniform regulations. To ensure quality and safety of care, it is prudent to set benchmarks for proper supervision and utilization of procedures in dermatology.
- Published
- 2023
15. Therapeutic targeting of TEAD transcription factors in cancer
- Author
-
Ajaybabu V. Pobbati, Ramesh Kumar, Brian P. Rubin, and Wanjin Hong
- Subjects
Molecular Biology ,Biochemistry - Published
- 2023
16. The Psychological Science Accelerator’s COVID-19 rapid-response dataset
- Author
-
Buchanan, Erin M., Lewis, Savannah C., Paris, Bastien, Forscher, Patrick S., Pavlacic, Jeffrey M., Beshears, Julie E., Drexler, Shira Meir, Gourdon-Kanhukamwe, Amélie, Mallik, Peter R., Silan, Miguel Alejandro A., Miller, Jeremy K., IJzerman, Hans, Moshontz, Hannah, Beaudry, Jennifer L., Suchow, Jordan W., Chartier, Christopher R., Coles, Nicholas A., Sharifian, Mohammad Hasan, Todsen, Anna Louise, Levitan, Carmel A., Azevedo, Flávio, Legate, Nicole, Heller, Blake, Rothman, Alexander J., Dorison, Charles A., Gill, Brian P., Wang, Ke, Rees, Vaughan W., Gibbs, Nancy, Goldenberg, Amit, Thi Nguyen, Thuy vy, Gross, James J., Kaminski, Gwenaêl, von Bastian, Claudia C., Paruzel-Czachura, Mariola, Mosannenzadeh, Farnaz, Azouaghe, Soufian, Bran, Alexandre, Ruiz-Fernandez, Susana, Santos, Anabela Caetano, Reggev, Niv, Zickfeld, Janis H., Akkas, Handan, Pantazi, Myrto, Ropovik, Ivan, Korbmacher, Max, Arriaga, Patrícia, Gjoneska, Biljana, Warmelink, Lara, Alves, Sara G., de Holanda Coelho, Gabriel Lins, Stieger, Stefan, Schei, Vidar, Hanel, Paul H.P., Szaszi, Barnabas, Fedotov, Maksim, Antfolk, Jan, Marcu, Gabriela Mariana, Schrötter, Jana, Kunst, Jonas R., Geiger, Sandra J., Adetula, Adeyemi, Kocalar, Halil Emre, Kielińska, Julita, Kačmár, Pavol, Bokkour, Ahmed, Galindo-Caballero, Oscar J., Djamai, Ikhlas, Pöntinen, Sara Johanna, Agesin, Bamikole Emmanuel, Jernsäther, Teodor, Urooj, Anum, Rachev, Nikolay R., Koptjevskaja-Tamm, Maria, Kurfalı, Murathan, Pit, Ilse L., Li, Ranran, Çoksan, Sami, Dubrov, Dmitrii, Paltrow, Tamar Elise, Baník, Gabriel, Korobova, Tatiana, Studzinska, Anna, Jiang, Xiaoming, Aruta, John Jamir Benzon R., Vintr, Jáchym, Chiu, Faith, Kaliska, Lada, Berkessel, Jana B., Tümer, Murat, Morales-Izquierdo, Sara, Chuan-Peng, Hu, Vezirian, Kevin, Rosa, Anna Dalla, Bialobrzeska, Olga, Vasilev, Martin R., Beitner, Julia, Kácha, Ondřej, Žuro, Barbara, Westerlund, Minja, Nedelcheva-Datsova, Mina, Findor, Andrej, Krupić, Dajana, Kowal, Marta, Askelund, Adrian Dahl, Pourafshari, Razieh, Đorđević, Jasna Milošević, Schmidt, Nadya Daniela, Baklanova, Ekaterina, Szala, Anna, Zakharov, Ilya, Vranka, Marek A., Ihaya, Keiko, Grano, Caterina, Cellini, Nicola, Białek, Michał, Anton-Boicuk, Lisa, Dalgar, Ilker, Adıgüzel, Arca, Verharen, Jeroen P.H., Maturan, Princess Lovella G., Kassianos, Angelos P., Oliveira, Raquel, Čadek, Martin, Adoric, Vera Cubela, Özdoğru, Asil Ali, Sverdrup, Therese E., Aczel, Balazs, Zambrano, Danilo, Ahmed, Afroja, Tamnes, Christian K., Yamada, Yuki, Volz, Leonhard, Sunami, Naoyuki, Suter, Lilian, Vieira, Luc, Groyecka-Bernard, Agata, Kamburidis, Julia Arhondis, Reips, Ulf Dietrich, Harutyunyan, Mikayel, Adetula, Gabriel Agboola, Allred, Tara Bulut, Barzykowski, Krystian, Antazo, Benedict G., Zsido, Andras N., Šakan, Dušana Dušan, Cyrus-Lai, Wilson, Ahlgren, Lina Pernilla, Hruška, Matej, Vega, Diego, Manunta, Efisio, Mokady, Aviv, Capizzi, Mariagrazia, Martončik, Marcel, Say, Nicolas, Filip, Katarzyna, Vilar, Roosevelt, Staniaszek, Karolina, Vdovic, Milica, Adamkovic, Matus, Johannes, Niklas, Hajdu, Nandor, Cohen, Noga, Overkott, Clara, Krupić, Dino, Hubena, Barbora, Nilsonne, Gustav, Mioni, Giovanna, Solorzano, Claudio Singh, Ishii, Tatsunori, Chen, Zhang, Kushnir, Elizaveta, Karaarslan, Cemre, Ribeiro, Rafael R., Khaoudi, Ahmed, Kossowska, Małgorzata, Bavolar, Jozef, Hoyer, Karlijn, Roczniewska, Marta, Karababa, Alper, Becker, Maja, Monteiro, Renan P., Kunisato, Yoshihiko, Metin-Orta, Irem, Adamus, Sylwia, Kozma, Luca, Czarnek, Gabriela, Domurat, Artur, Štrukelj, Eva, Alvarez, Daniela Serrato, Parzuchowski, Michal, Massoni, Sébastien, Czamanski-Cohen, Johanna, Pronizius, Ekaterina, Muchembled, Fany, van Schie, Kevin, Saçaklı, Aslı, Hristova, Evgeniya, Kuzminska, Anna O., Charyate, Abdelilah, Bijlstra, Gijsbert, Afhami, Reza, Majeed, Nadyanna M., Musser, Erica D., Sirota, Miroslav, Ross, Robert M., Yeung, Siu Kit, Papadatou-Pastou, Marietta, Foroni, Francesco, Almeida, Inês A.T., Grigoryev, Dmitry, Lewis, David M.G., Holford, Dawn L., Janssen, Steve M.J., Tatachari, Srinivasan, Batres, Carlota, Olofsson, Jonas K., Daches, Shimrit, Belaus, Anabel, Pfuhl, Gerit, Corral-Frias, Nadia Sarai, Sousa, Daniela, Röer, Jan Philipp, Isager, Peder Mortvedt, Godbersen, Hendrik, Walczak, Radoslaw B., Van Doren, Natalia, Ren, Dongning, Gill, Tripat, Voracek, Martin, DeBruine, Lisa M., Anne, Michele, Očovaj, Sanja Batić, Thomas, Andrew G., Arvanitis, Alexios, Ostermann, Thomas, Wolfe, Kelly, Arinze, Nwadiogo Chisom, Bundt, Carsten, Lamm, Claus, Calin-Jageman, Robert J., Davis, William E., Karekla, Maria, Zorjan, Saša, Jaremka, Lisa M., Uttley, Jim, Hricova, Monika, Koehn, Monica A., Kiselnikova, Natalia, Bai, Hui, Krafnick, Anthony J., Balci, Busra Bahar, Ballantyne, Tonia, Lins, Samuel, Vally, Zahir, Esteban-Serna, Celia, Schmidt, Kathleen, Macapagal, Paulo Manuel L., Szwed, Paulina, Zdybek, Przemysław Marcin, Moreau, David, Collins, W. Matthew, Joy-Gaba, Jennifer A., Vilares, Iris, Tran, Ulrich S., Boudesseul, Jordane, Albayrak-Aydemir, Nihan, Dixson, Barnaby James Wyld, Perillo, Jennifer T., Ferreira, Ana, Westgate, Erin C., Aberson, Christopher L., Arinze, Azuka Ikechukwu, Jaeger, Bastian, Butt, Muhammad Mussaffa, Silva, Jaime R., Storage, Daniel Shafik, Janak, Allison P., Jiménez-Leal, William, Soto, Jose A., Sorokowska, Agnieszka, McCarthy, Randy, Tullett, Alexa M., Frias-Armenta, Martha, Ribeiro, Matheus Fernando Felix, Hartanto, Andree, Forbes, Paul A.G., Willis, Megan L., del Carmen Tejada R, María, Torres, Adriana Julieth Olaya, Stephen, Ian D., Vaidis, David C., de la Rosa-Gómez, Anabel, Yu, Karen, Sutherland, Clare A.M., Manavalan, Mathi, Behzadnia, Behzad, Urban, Jan, Baskin, Ernest, McFall, Joseph P., Ogbonnaya, Chisom Esther, Fu, Cynthia H.Y., Rahal, Rima Maria, Ndukaihe, Izuchukwu L.G., Hostler, Thomas J., Kappes, Heather Barry, Sorokowski, Piotr, Khosla, Meetu, Lazarevic, Ljiljana B., Eudave, Luis, Vilsmeier, Johannes K., Luis, Elkin O., Muda, Rafał, Agadullina, Elena, Cárcamo, Rodrigo A., Reeck, Crystal, Anjum, Gulnaz, Venegas, Mónica Camila Toro, Misiak, Michal, Ryan, Richard M., Nock, Nora L., Travaglino, Giovanni A., Mensink, Michael C., Feldman, Gilad, Wichman, Aaron L., Chou, Weilun, Ziano, Ignazio, Seehuus, Martin, Chopik, William J., Kung, Franki Y.H., Carpentier, Joelle, Vaughn, Leigh Ann, Du, Hongfei, Xiao, Qinyu, Lima, Tiago J.S., Noone, Chris, Onie, Sandersan, Verbruggen, Frederick, Radtke, Theda, Primbs, Maximilian A., Lewis, David M. G., Buchanan, Erin M [0000-0002-9689-4189], Lewis, Savannah C [0000-0002-9948-1195], Paris, Bastien [0000-0002-7197-8001], Forscher, Patrick S [0000-0002-7763-3565], Silan, Miguel Alejandro A [0000-0002-7480-3661], IJzerman, Hans [0000-0002-0990-2276], Suchow, Jordan W [0000-0001-9848-4872], Coles, Nicholas A [0000-0001-8583-5610], Levitan, Carmel A [0000-0001-5403-444X], Azevedo, Flávio [0000-0001-9000-8513], Legate, Nicole [0000-0001-8086-9643], Rees, Vaughan W [0000-0002-9939-6740], von Bastian, Claudia C [0000-0002-0667-2460], Ruiz-Fernandez, Susana [0000-0002-1709-1506], Reggev, Niv [0000-0002-5734-7457], Zickfeld, Janis H [0000-0001-7660-2719], Akkas, Handan [0000-0002-2082-0685], Ropovik, Ivan [0000-0001-5222-1233], Gjoneska, Biljana [0000-0003-1200-6672], Warmelink, Lara [0000-0003-1218-9448], Stieger, Stefan [0000-0002-7784-6624], Fedotov, Maksim [0000-0002-7100-1719], Antfolk, Jan [0000-0003-0334-4987], Marcu, Gabriela-Mariana [0000-0003-2508-3749], Schrötter, Jana [0000-0002-9830-6184], Geiger, Sandra J [0000-0002-3262-5609], Adetula, Adeyemi [0000-0001-9344-576X], Kačmár, Pavol [0000-0003-0076-1945], Galindo-Caballero, Oscar J [0000-0003-4603-6415], Jernsäther, Teodor [0000-0002-7030-3299], Rachev, Nikolay R [0000-0002-5654-2883], Koptjevskaja-Tamm, Maria [0000-0002-9592-5780], Pit, Ilse L [0000-0002-4066-8086], Li, Ranran [0000-0001-9145-4240], Baník, Gabriel [0000-0002-6601-3619], Studzinska, Anna [0000-0002-7694-4214], Berkessel, Jana B [0000-0001-5053-6901], Morales-Izquierdo, Sara [0000-0003-3240-9348], Chuan-Peng, Hu [0000-0002-7503-5131], Beitner, Julia [0000-0002-2539-7011], Kowal, Marta [0000-0001-9050-1471], Schmidt, Nadya-Daniela [0000-0002-7229-2132], Szala, Anna [0000-0002-9693-9834], Vranka, Marek A [0000-0003-3413-9062], Białek, Michał [0000-0002-5062-5733], Maturan, Princess Lovella G [0000-0001-6762-1475], Kassianos, Angelos P [0000-0001-6428-2623], Adoric, Vera Cubela [0000-0003-4752-4541], Aczel, Balazs [0000-0001-9364-4988], Yamada, Yuki [0000-0003-1431-568X], Volz, Leonhard [0000-0001-7954-3793], Sunami, Naoyuki [0000-0001-5482-8370], Suter, Lilian [0000-0001-5655-3729], Mokady, Aviv [0000-0003-4475-0332], Adamkovic, Matus [0000-0002-9648-9108], Cohen, Noga [0000-0002-7682-0289], Krupić, Dino [0000-0003-4383-7807], Nilsonne, Gustav [0000-0001-5273-0150], Solorzano, Claudio Singh [0000-0003-0402-4969], Bavolar, Jozef [0000-0003-0179-7261], Becker, Maja [0000-0003-1187-1699], Kozma, Luca [0000-0002-3297-629X], Domurat, Artur [0000-0001-5533-9106], Parzuchowski, Michal [0000-0002-8960-0277], Czamanski-Cohen, Johanna [0000-0003-3980-6848], Pronizius, Ekaterina [0000-0003-1446-196X], Musser, Erica D [0000-0003-0966-4068], Sirota, Miroslav [0000-0003-2117-9532], Ross, Robert M [0000-0001-8711-1675], Foroni, Francesco [0000-0002-4702-3678], Almeida, Inês AT [0000-0003-0230-3075], Grigoryev, Dmitry [0000-0003-4511-7942], Lewis, David MG [0000-0002-8267-5727], Holford, Dawn L [0000-0002-6392-3991], Janssen, Steve MJ [0000-0002-3100-128X], Tatachari, Srinivasan [0000-0003-1838-2361], Batres, Carlota [0000-0002-3833-7667], Olofsson, Jonas K [0000-0002-0856-0569], Belaus, Anabel [0000-0001-9657-8496], Pfuhl, Gerit [0000-0002-3271-6447], Voracek, Martin [0000-0001-6109-6155], DeBruine, Lisa M [0000-0002-7523-5539], Arvanitis, Alexios [0000-0002-3379-0286], Arinze, Nwadiogo Chisom [0000-0002-2531-6250], Lamm, Claus [0000-0002-5422-0653], Calin-Jageman, Robert J [0000-0002-9837-6529], Karekla, Maria [0000-0001-7021-7908], Hricova, Monika [0000-0001-9873-5475], Koehn, Monica A [0000-0002-4413-7709], Krafnick, Anthony J [0000-0002-1692-0413], Lins, Samuel [0000-0001-6824-4691], Albayrak-Aydemir, Nihan [0000-0003-3412-4311], Dixson, Barnaby James Wyld [0000-0003-0911-1244], Butt, Muhammad Mussaffa [0000-0001-5271-111X], Sorokowska, Agnieszka [0000-0003-3999-8851], Willis, Megan L [0000-0002-2310-0018], Stephen, Ian D [0000-0001-9714-8295], Ogbonnaya, Chisom Esther [0000-0001-6392-0865], Fu, Cynthia HY [0000-0003-4313-3500], Rahal, Rima-Maria [0000-0002-1404-0471], Lazarevic, Ljiljana B [0000-0003-1629-3699], Reeck, Crystal [0000-0002-1540-5321], Travaglino, Giovanni A [0000-0003-4091-0634], Chopik, William J [0000-0003-1748-8738], Xiao, Qinyu [0000-0002-9824-9247], Verbruggen, Frederick [0000-0002-7958-0719], Apollo - University of Cambridge Repository, MÜ, Eğitim Fakültesi, Eğitim Bilimleri Bölümü, Kocalar, Halil Emre, Repositório da Universidade de Lisboa, Organizational Psychology, Center Ph. D. Students, Department of Social Psychology, Medical and Clinical Psychology, Clinical Psychology, and Faculdade de Psicologia e de Ciências da Educação
- Subjects
Statistics and Probability ,223 participants with varying completion rates. Participants completed the survey from 111 geopolitical regions in 44 unique languages/dialects. The anonymized dataset described here is provided in both raw and processed formats to facilitate re-use and further analyses. The dataset offers secondary analytic opportunities to explore coping ,BF Psychology ,230 Affective Neuroscience ,Health Behavior ,and demographic information for each participant. Each participant started the study with the same general questions and then was randomized to complete either one longer experiment or two shorter experiments. Data were provided by 73 ,Message framing ,Diseases ,Library and Information Sciences ,Ciências Sociais::Psicologia [Domínio/Área Científica] ,geographical and cultural context characterization ,HV Social pathology. Social and public welfare. Criminology ,pandemiat ,Education ,a general questionnaire examining health prevention behaviors and COVID-19 experience ,ddc:150 ,SDG 3 - Good Health and Well-being ,RA0421 Public health. Hygiene. Preventive Medicine ,Surveys and Questionnaires ,Adaptation, Psychological ,yleiskartoitukset ,Humans ,Pendiente ,Health behaviors ,Pandemics ,framing ,Behaviour Change and Well-being ,Emotion regulation ,Self-determination messaging ,and self-determination across a diverse ,COVID-19 ,kansainvälinen vertailu ,Research data ,Computer Science Applications ,which can be merged with other time-sampled or geographic data ,cognitive reappraisals ,global sample obtained at the onset of the COVID-19 pandemic ,terveyskäyttäytyminen ,In response to the COVID-19 pandemic ,and autonomy framing manipulations on behavioral intentions and affective measures. The data collected (April to October 2020) included specific measures for each experimental study ,Statistics, Probability and Uncertainty ,People’s health ,tutkimusaineisto ,survey-tutkimus ,Dataset ,Information Systems ,the Psychological Science Accelerator coordinated three large-scale psychological studies to examine the effects of loss-gain framing - Abstract
Funder: Amazon Web Services (AWS) Imagine Grant, Funder: Kingston University (Kingston University, London); doi: https://doi.org/10.13039/100010049, Funder: Association Nationale de la Recherche et de la Technologie (National Association for Research and Technology); doi: https://doi.org/10.13039/501100003032, Funder: Association Nationale de la Recherche Scientifique and Pacifica (CIFRE grant 2017/0245), Funder: PRIMUS/20/HUM/009, Funder: UID/PSI/03125/2019 from the Portuguese National Foundation for Science and Technology (FCT)., Funder: PSA research grant ($285.59) for the PSACR projects data collection, Funder: The work of Dmitrii Dubrov was supported within the framework of the Basic Research Program at HSE University, RF, Funder: Agentúra na podporu výskumu a vývoja (Slovak Research and Development Agency) - APVV-17-0596, Funder: Progres Q18, Charles University, Funder: JSPS KAKENHI Grant Numbers JP18K12015 and JP20H04581, Funder: National Science Centre, Poland (2019/35/B/HS6/00528), Funder: Slovak Research and Development Agency - APVV-17-0596, Funder: Huo Family Foundation, Funder: The Japan Society for the Promotion of Science KAKENHI [19K14370], Funder: The Institute of Psychology, Jagiellonian University, Funder: Program FUTURE LEADER of Lorraine Université d’Excellence within the program Investissements Avenir (ANR-15-IDEX-04-LUE) operated by the French National Research Agency, Funder: Rubicon grant (019.183SG.007) from the Netherlands Organization for Scientific Research (NWO), Funder: Australian Research Council (DP180102384), Funder: HSE University Basic Research Program, Funder: Horizon 2020 grant 964728 (JITSUVAX) from the European Commission and was supported by a United Kingdom Research and Innovation (UKRI) Research Fellowship grant ES/V011901/1, Funder: Social Science and Humanities Research Council of Canada, Funder: Dominican University Faculty Support Grant, Funder: FONDECYT 1221538, Funder: Vicerrectoria de Investigaciones, Uniandes, Funder: Statutory funds of the Institute of Psychology, University of Wroclaw, Funder: University of Desarrollo, Faculty of Psychology, Funder: IDN Being Human Lab (University of Wrocław), Funder: ANID - Fondecyt 1201513, In response to the COVID-19 pandemic, the Psychological Science Accelerator coordinated three large-scale psychological studies to examine the effects of loss-gain framing, cognitive reappraisals, and autonomy framing manipulations on behavioral intentions and affective measures. The data collected (April to October 2020) included specific measures for each experimental study, a general questionnaire examining health prevention behaviors and COVID-19 experience, geographical and cultural context characterization, and demographic information for each participant. Each participant started the study with the same general questions and then was randomized to complete either one longer experiment or two shorter experiments. Data were provided by 73,223 participants with varying completion rates. Participants completed the survey from 111 geopolitical regions in 44 unique languages/dialects. The anonymized dataset described here is provided in both raw and processed formats to facilitate re-use and further analyses. The dataset offers secondary analytic opportunities to explore coping, framing, and self-determination across a diverse, global sample obtained at the onset of the COVID-19 pandemic, which can be merged with other time-sampled or geographic data.
- Published
- 2023
17. Associations of vulnerability to stressful life events with suicide attempts after active duty among high-risk soldiers: results from the Study to Assess Risk and Resilience in Servicemembers-longitudinal study (STARRS-LS)
- Author
-
Carol Chu, Ian H. Stanley, Brian P. Marx, Andrew J. King, Dawne Vogt, Sarah M. Gildea, Irving H. Hwang, Nancy A. Sampson, Robert O'Brien, Murray B. Stein, Robert J. Ursano, and Ronald C. Kessler
- Subjects
Psychiatry and Mental health ,Applied Psychology - Abstract
Background The transition from military service to civilian life is a high-risk period for suicide attempts (SAs). Although stressful life events (SLEs) faced by transitioning soldiers are thought to be implicated, systematic prospective evidence is lacking. Methods Participants in the Army Study to Assess Risk and Resilience in Servicemembers (STARRS) completed baseline self-report surveys while on active duty in 2011–2014. Two self-report follow-up Longitudinal Surveys (LS1: 2016–2018; LS2: 2018–2019) were subsequently administered to probability subsamples of these baseline respondents. As detailed in a previous report, a SA risk index based on survey, administrative, and geospatial data collected before separation/deactivation identified 15% of the LS respondents who had separated/deactivated as being high-risk for self-reported post-separation/deactivation SAs. The current report presents an investigation of the extent to which self-reported SLEs occurring in the 12 months before each LS survey might have mediated/modified the association between this SA risk index and post-separation/deactivation SAs. Results The 15% of respondents identified as high-risk had a significantly elevated prevalence of some post-separation/deactivation SLEs. In addition, the associations of some SLEs with SAs were significantly stronger among predicted high-risk than lower-risk respondents. Demographic rate decomposition showed that 59.5% (s.e. = 10.2) of the overall association between the predicted high-risk index and subsequent SAs was linked to these SLEs. Conclusions It might be possible to prevent a substantial proportion of post-separation/deactivation SAs by providing high-risk soldiers with targeted preventive interventions for exposure/vulnerability to commonly occurring SLEs.
- Published
- 2023
18. Associations of medication with subcortical morphology across the lifespan in OCD: Results from the international ENIGMA Consortium
- Author
-
Iliyan Ivanov, Premika S.W. Boedhoe, Yoshinari Abe, Pino Alonso, Stephanie H. Ameis, Paul D. Arnold, Srinivas Balachander, Justin T. Baker, Nerisa Banaj, Nuria Bargalló, Marcelo C. Batistuzzo, Francesco Benedetti, Jan C. Beucke, Irene Bollettini, Silvia Brem, Brian P. Brennan, Jan Buitelaar, Rosa Calvo, Yuqi Cheng, Kang Ik K. Cho, Sara Dallaspezia, Damiaan Denys, Juliana B. Diniz, Benjamin A. Ely, Jamie D. Feusner, Sónia Ferreira, Kate D. Fitzgerald, Martine Fontaine, Patricia Gruner, Gregory L. Hanna, Yoshiyuki Hirano, Marcelo Q. Hoexter, Chaim Huyser, Keisuke Ikari, Anthony James, Fern Jaspers-Fayer, Hongyan Jiang, Norbert Kathmann, Christian Kaufmann, Minah Kim, Kathrin Koch, Jun Soo Kwon, Luisa Lázaro, Yanni Liu, Christine Lochner, Rachel Marsh, Ignacio Martínez-Zalacaín, David Mataix-Cols, José M. Menchón, Luciano Minuzzi, Astrid Morer, Pedro Morgado, Akiko Nakagawa, Takashi Nakamae, Tomohiro Nakao, Janardhanan C. Narayanaswamy, Erika L. Nurmi, Sanghoon Oh, Chris Perriello, John C. Piacentini, Maria Picó-Pérez, Fabrizio Piras, Federica Piras, Y.C. Janardhan Reddy, Daniela Rodriguez Manrique, Yuki Sakai, Eiji Shimizu, H. Blair Simpson, Noam Soreni, Carles Soriano-Mas, Gianfranco Spalletta, Emily R. Stern, Michael C. Stevens, S. Evelyn Stewart, Philip R. Szeszko, David F. Tolin, Daan van Rooij, Dick J. Veltman, Ysbrand D. van der Werf, Guido A. van Wingen, Ganesan Venkatasubramanian, Susanne Walitza, Zhen Wang, Anri Watanabe, Lidewij H. Wolters, Xiufeng Xu, Je-Yeon Yun, Mojtaba Zarei, Fengrui Zhang, Qing Zhao, Neda Jahanshad, Sophia I. Thomopoulos, Paul M. Thompson, Dan J. Stein, Odile A. van den Heuvel, Joseph O'Neill, Sara Poletti, Egill Axfjord Fridgeirsson, Toshikazu Ikuta, Stella J. de Wit, Chris Vriend, Selina Kasprzak, Masaru Kuno, Jumpei Takahashi, Euripedes C. Miguel, Roseli G. Shavitt, Morgan Hough, Jose C. Pariente, Ana E. Ortiz, Sara Bertolín, Eva Real, Cinto Segalàs, Pedro Silva Moreira, Nuno Sousa, Jin Narumoto, Kei Yamada, Jinsong Tang, Jean-Paul Fouche, Taekwan Kim, Sunah Choi, Minji Ha, Sunghyun Park, Anatomy and neurosciences, Psychiatry, Amsterdam Neuroscience - Brain Imaging, Amsterdam Neuroscience - Mood, Anxiety, Psychosis, Stress & Sleep, Amsterdam Neuroscience - Compulsivity, Impulsivity & Attention, Amsterdam Neuroscience - Systems & Network Neuroscience, Amsterdam Neuroscience - Neurodegeneration, Adult Psychiatry, Child Psychiatry, Paediatric Psychosocial Care, Amsterdam Neuroscience - Cellular & Molecular Mechanisms, Graduate School, Ivanov, Iliyan, Boedhoe, Premika S W, Abe, Yoshinari, Alonso, Pino, Ameis, Stephanie H, Arnold, Paul D, Balachander, Sriniva, Baker, Justin T, Banaj, Nerisa, Bargalló, Nuria, Batistuzzo, Marcelo C, Benedetti, Francesco, Beucke, Jan C, Bollettini, Irene, Brem, Silvia, Brennan, Brian P, Buitelaar, Jan, Calvo, Rosa, Cheng, Yuqi, Cho, Kang Ik K, Dallaspezia, Sara, Denys, Damiaan, Diniz, Juliana B, Ely, Benjamin A, Feusner, Jamie D, Ferreira, Sónia, Fitzgerald, Kate D, Fontaine, Martine, Gruner, Patricia, Hanna, Gregory L, Hirano, Yoshiyuki, Hoexter, Marcelo Q, Huyser, Chaim, Ikari, Keisuke, James, Anthony, Jaspers-Fayer, Fern, Jiang, Hongyan, Kathmann, Norbert, Kaufmann, Christian, Kim, Minah, Koch, Kathrin, Kwon, Jun Soo, Lázaro, Luisa, Liu, Yanni, Lochner, Christine, Marsh, Rachel, Martínez-Zalacaín, Ignacio, Mataix-Cols, David, Menchón, José M, Minuzzi, Luciano, Morer, Astrid, Morgado, Pedro, Nakagawa, Akiko, Nakamae, Takashi, Nakao, Tomohiro, Narayanaswamy, Janardhanan C, Nurmi, Erika L, Oh, Sanghoon, Perriello, Chri, Piacentini, John C, Picó-Pérez, Maria, Piras, Fabrizio, Piras, Federica, Reddy, Y C Janardhan, Manrique, Daniela Rodriguez, Sakai, Yuki, Shimizu, Eiji, Simpson, H Blair, Soreni, Noam, Soriano-Mas, Carle, Spalletta, Gianfranco, Stern, Emily R, Stevens, Michael C, Stewart, S Evelyn, Szeszko, Philip R, Tolin, David F, van Rooij, Daan, Veltman, Dick J, van der Werf, Ysbrand D, van Wingen, Guido A, Venkatasubramanian, Ganesan, Walitza, Susanne, Wang, Zhen, Watanabe, Anri, Wolters, Lidewij H, Xu, Xiufeng, Yun, Je-Yeon, Zarei, Mojtaba, Zhang, Fengrui, Zhao, Qing, Jahanshad, Neda, Thomopoulos, Sophia I, Thompson, Paul M, Stein, Dan J, van den Heuvel, Odile A, and O'Neill, Joseph
- Subjects
Obsessive-Compulsive Disorder ,Neurodevelopmental disorders Donders Center for Medical Neuroscience [Radboudumc 7] ,OCD ,Psychotropics ,Longevity ,SRIs ,Magnetic Resonance Imaging ,Benzodiazepines ,Psychiatry and Mental health ,Clinical Psychology ,Age ,Cross-Sectional Studies ,Subcortical volumes ,130 000 Cognitive Neurology & Memory ,Child, Preschool ,Serotonin Uptake Inhibitors ,Humans ,Child ,Selective Serotonin Reuptake Inhibitors ,Aged ,Antipsychotic Agents - Abstract
Background: Widely used psychotropic medications for obsessive-compulsive disorder (OCD) may change the volumes of subcortical brain structures, and differently in children vs. adults. We measured subcortical volumes cross-sectionally in patients finely stratified for age taking various common classes of OCD drugs. Methods: The ENIGMA-OCD consortium sample (1081 medicated/1159 unmedicated OCD patients and 2057 healthy controls aged 6–65) was divided into six successive 6–10-year age-groups. Individual structural MRIs were parcellated automatically using FreeSurfer into 8 regions-of-interest (ROIs). ROI volumes were compared between unmedicated and medicated patients and controls, and between patients taking serotonin reuptake inhibitors (SRIs), tricyclics (TCs), antipsychotics (APs), or benzodiazepines (BZs) and unmedicated patients. Results: Compared to unmedicated patients, volumes of accumbens, caudate, and/or putamen were lower in children aged 6–13 and adults aged 50–65 with OCD taking SRIs (Cohen's d = −0.24 to −0.74). Volumes of putamen, pallidum (d = 0.18–0.40), and ventricles (d = 0.31–0.66) were greater in patients aged 20–29 receiving APs. Hippocampal volumes were smaller in patients aged 20 and older taking TCs and/or BZs (d = −0.27 to −1.31). Conclusions: Results suggest that TCs and BZs could potentially aggravate hippocampal atrophy of normal aging in older adults with OCD, whereas SRIs may reduce striatal volumes in young children and older adults. Similar to patients with psychotic disorders, OCD patients aged 20–29 may experience subcortical nuclear and ventricular hypertrophy in relation to APs. Although cross-sectional, present results suggest that commonly prescribed agents exert macroscopic effects on subcortical nuclei of unknown relation to therapeutic response.
- Published
- 2022
19. Prehospital Guidelines for the Management of Traumatic Brain Injury – 3rd Edition
- Author
-
Al Lulla, Angela Lumba-Brown, Annette M. Totten, Patrick J. Maher, Neeraj Badjatia, Randy Bell, Christina T. J. Donayri, Mary E. Fallat, Gregory W. J. Hawryluk, Scott A. Goldberg, Halim M. A. Hennes, Steven P. Ignell, Jamshid Ghajar, Brian P. Krzyzaniak, E. Brooke Lerner, Daniel Nishijima, Charles Schleien, Stacy Shackelford, Erik Swartz, David W. Wright, Rachel Zhang, Andy Jagoda, and Bentley J. Bobrow
- Subjects
Emergency Medicine ,Emergency Nursing - Published
- 2023
20. Study Abroad Enhances Cognitive Development
- Author
-
Chad N. Loes and Brian P. An
- Subjects
Education - Published
- 2023
21. To Err is AI: Imperfect Interventions and Repair in a Conversational Agent Facilitating Group Chat Discussions
- Author
-
Hyo Jin Do, Ha-Kyung Kong, Pooja Tetali, Jaewook Lee, and Brian P. Bailey
- Subjects
Human-Computer Interaction ,Computer Networks and Communications ,Social Sciences (miscellaneous) - Abstract
Conversational agents (CAs) can analyze online conversations using natural language techniques and effectively facilitate group discussions by sending supervisory messages. However, if a CA makes imperfect interventions, users may stop trusting the CA and discontinue using it. In this study, we demonstrate how inaccurate interventions of a CA and a conversational repair strategy can influence user acceptance of the CA, members' participation in the discussion, perceived discussion experience between the members, and group performance. We built a CA that encourages the participation of members with low contributions in an online chat discussion in which a small group (3-6 members) performs a decision-making task. Two types of errors can occur when detecting under-contributing members: 1) false-positive (FP) errors happen when the CA falsely identifies a member as under-contributing and 2) false-negative (FN) errors occur when the CA misses detecting an under-contributing member. We designed a conversational repair strategy that gives users a chance to contest the detection results and the agent sends a correctional message if an error is detected. Through an online study with 175 participants, we found that participants who received FN error messages reported higher acceptance of the CA and better discussion experience, but participated less compared to those who received FP error messages. The conversational repair strategy moderated the effect of errors such as improving the perceived discussion experience of participants who received FP error messages. Based on our findings, we offer design implications for which model should be selected by practitioners between high precision (i.e., fewer FP errors) and high recall (i.e., fewer FN errors) models depending on the desired effects. When frequent FP errors are expected, we suggest using the conversational repair strategy to improve the perceived discussion experience.
- Published
- 2023
22. The Value of Activity Traces in Peer Evaluations: An Experimental Study
- Author
-
Wenxuan Wendy Shi, Sneha R. Krishna Kumaran, Hari Sundaram, and Brian P. Bailey
- Subjects
Human-Computer Interaction ,Computer Networks and Communications ,Social Sciences (miscellaneous) - Abstract
Peer evaluations are a well-established tool for evaluating individual and team performance in collaborative contexts, but are susceptible to social and cognitive biases. Current peer evaluation tools have also yet to address the unique opportunities that online collaborative technologies provide for addressing these biases. In this work, we explore the potential of one such opportunity for peer evaluations: data traces automatically generated by collaborative tools, which we refer to as "activity traces". We conduct a between-subjects experiment with 101 students and MTurk workers, investigating the effects of reviewing activity traces on peer evaluations of team members in an online collaborative task. Our findings show that the usage of activity traces led participants to make more and greater revisions to their evaluations compared to a control condition. These revisions also increased the consistency and participants' perceived accuracy of the evaluations that they received. Our findings demonstrate the value of activity traces as an approach for performing more reliable and objective peer evaluations of teamwork. Based on our findings as well as qualitative analysis of free-form responses in our study, we also identify and discuss key considerations and design recommendations for incorporating activity traces into real-world peer evaluation systems.
- Published
- 2023
23. Accelerated Event Times with Multiple Thresholds
- Author
-
Brian P. Weaver and Scott A. Vander Wiel
- Subjects
Statistics and Probability ,Applied Mathematics ,Modeling and Simulation - Published
- 2023
24. Advances in multi-modality imaging for constrictive pericarditis and pericardial inflammation: role of imaging-guided therapy
- Author
-
Tahir S Kafil, Tom Kai Ming Wang, Ankit Agrawal, Muhammad Majid, Alveena B Syed, Erika Hutt, Ben Alencherry, Joshua A Cohen, Sachin Kumar, Agam Bansal, Brian P Griffin, and Allan L Klein
- Subjects
Internal Medicine ,General Medicine ,Cardiology and Cardiovascular Medicine - Published
- 2023
25. Ophthalmic Manifestations of ROSAH (Retinal Dystrophy, Optic Nerve Edema, Splenomegaly, Anhidrosis, and Headache) Syndrome, an Inherited NF κB–Mediated Autoinflammatory Disease with Retinal Dystrophy
- Author
-
Laryssa A. Huryn, Christina Torres Kozycki, Jasmine Y. Serpen, Wadih M. Zein, Ehsan Ullah, Alessandro Iannaccone, Lloyd B. Williams, Lucia Sobrin, Brian P. Brooks, H. Nida Sen, Robert B. Hufnagel, Daniel L. Kastner, and Shilpa Kodati
- Subjects
Ophthalmology - Published
- 2023
26. Post-Acute SARS-CoV-2 Symptoms are Fewer, Less Intense Over Time in People Treated with Mono-Clonal Antibodies for Acute Infection
- Author
-
Jillian Kallman Price, Lynn H Gerber, Maria Stepanova, Leyla de Avila, Ali A Weinstein, Huong Pham, Fatema Nader, Mariam Afendy, Kathy Terra, Patrick Austin, Wisna’odom Keo, Andrei Racila, James Michael Estep, Suzannah Gerber, Manisha Verma, Pegah Golabi, Brian P Lam, and Zobair Younossi
- Subjects
International Journal of General Medicine ,General Medicine - Abstract
Jillian Kallman Price,1 Lynn H Gerber,1,2 Maria Stepanova,1â 3 Leyla de Avila,1 Ali A Weinstein,4 Huong Pham,1 Fatema Nader,1 Mariam Afendy,1 Kathy Terra,3 Patrick Austin,1 Wisnaâodom Keo,1 Andrei Racila,1 James Michael Estep,1 Suzannah Gerber,1 Manisha Verma,1 Pegah Golabi,1 Brian P Lam,1â 3 Zobair Younossi1â 3 1Betty and Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, VA, USA; 2Inova Medicine, Inova Health System, Falls Church, VA, USA; 3Center for Liver Disease, Department of Medicine, Inova Fairfax Medical Campus, Falls Church, VA, USA; 4Department of Global and Community Health, George Mason University, Fairfax, VA, USACorrespondence: Jillian Kallman Price, Research Investigator, Outcomes Research, Beatty Liver and Obesity Research Program, Center for Integrated Research, Department of Medicine, Inova Health System, Claude Moore Health Education and Research Building, Inova Fairfax Medical Campus, 3300 Gallows Road, Falls Church, VA, 22042, USA, Tel +1-703-776-3032, Fax +1-703- 776-4386, Email Jillian.Price@inova.orgIntroduction: Many with post-acute SARS-CoV-2 (PASC) have persistent symptoms impacting physical and cognitive function, decreased health and health-related life quality. Monoclonal antibody (mAb) treatment was available to acutely infected patients which might improve these outcomes.Purpose: To compare patient perception of PASC symptoms for those receiving bamlanivimab or casirivimab and imdevimab (mAbs) to those not receiving this treatment (non-mAbs). To compare changes between these groups in symptoms, function and quality of life over a 6-month follow-up.Patients and Methods: Consented adults > 28 days post-infection with positive SARS-CoV-2 qPCR or antigen test and SARS-CoV-2 infection between March of 2020 and July of 2022 were enrolled. This prospective, repeated measure observational study reports baseline through 6-month follow-up. Extensive sociodemographic data, detailed medical history, COVID-19 symptom history, and standardized measures of well-being, depression, anxiety, stigma, cognition, symptom assessment, distress, and health status were collected.Results: 323 participants [101 mAb, 221 non-mAb, 52.7± 15.5 years, 47.7% male, body mass index (BMI) 31.4± 8.4] were analyzed. Fewer symptoms at baseline were reported in mAb versus non-mAb participants (1.06± 1.31 vs 1.78± 2.15, respectively p=0.0177) 6 months: (0.911± 1.276 mAb vs.1.75± 2.22 non-mAb, p=0.0427). Both groups showed significant within-group decreases in symptom number (52 to 21 mAb, 126 to 63 non-mAb) and symptom burden (p=0.0088 mAb, p< 0.00001 non-mAb). mAb patients had significantly shorter infection-to-baseline interval (days) (120.4± 55.3 mAb vs 194.0± 89.3 non-mAb, p< 0.00001); less frequent history of myocardial infarction (0.0 vs 3.9%, p=0.0464); headache (2.0% vs.11.8%, p=0.0046), rash (3.1% vs 9.9%, p=0.0377), and miscellaneous muscle complaints (2.0% vs 12.3%, p=0.0035), plus significantly better 6-month mood. (2.2% vs 13.2%, p=0.0390).Conclusion: mAb treated participants had reduced symptom burden and consistently reported fewer symptoms than non-mAb at all time points despite less time since acute illness. Both groups reported a statistically significant decrease in symptoms by 6-month visit with no statistically significant differences between them at follow-up.Keywords: monoclonal antibodies, patient-reported outcomes, symptom burden, recovery, COVID-19
- Published
- 2023
27. Severe mitral regurgitation in nonagenarians: Impact of symptomatic status, frailty and etiology on management and outcomes
- Author
-
Alejandro Duran Crane, Yoshihito Saijo, Duygu Kocyigit, Arsal Tharwani, Sudarshana Datta, Carlos Godoy Rivas, A. Marc Gillinov, Samir R. Kapadia, Amar Krishnaswamy, Richard A. Grimm, Brian P. Griffin, and Bo Xu
- Subjects
Cardiology and Cardiovascular Medicine - Published
- 2023
28. Discontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trials
- Author
-
Nicole Mayer-Hamblett, Felix Ratjen, Renee Russell, Scott H Donaldson, Kristin A Riekert, Gregory S Sawicki, Katherine Odem-Davis, Julia K Young, Daniel Rosenbluth, Jennifer L Taylor-Cousar, Christopher H Goss, George Retsch-Bogart, John Paul Clancy, Alan Genatossio, Brian P O'Sullivan, Ariel Berlinski, Susan L Millard, Gregory Omlor, Colby A Wyatt, Kathryn Moffett, David P Nichols, Alex H Gifford, Margaret Kloster, Katie Weaver, Claire Chapdu, Jing Xie, Michelle Skalland, Melita Romasco, Sonya Heltshe, Noah Simon, Jill VanDalfsen, Anna Mead, Rachael Buckingham, Kathy Seidel, Nikita Midamba, Laurel Couture, Brooke Zappone Case, Wendy Au, Elsie Rockers, Diane Cooke, Amber Olander, Irene Bondick, Miya Johnson, Lisya VanHousen, Boris Nicholson, Michelle Parrish, Dion Roberts, Jillian Head, Jessica Carey, Lindsay Caverly, Joy Dangerfield, Rachel Linnemann, Jason Fullmer, Chelsea Roman, Peter Mogayzel, Deanne Reyes, Amy Harmala, Jerimiah Lysinger, Jonathan Bergeron, Isabel Virella-Lowell, Perry Brown, Lejla Godusevic, Alicia Casey, Lauren Paquette, Thomas Lahiri, Julie Sweet, Scott Donaldson, Joshua Harris, Shelia Parnell, Sylvia Szentpetery, Deborah Froh, Erica Tharrington, Manu Jain, Rachel Nelson, Sharon Kadon, Gary McPhail, Kimberly McBennett, Tia Rone, Elliott Dasenbrook, Dave Weaver, Terri Johnson, Karen McCoy, Raksha Jain, Maria Mcleod, Mary Klosterman, Preeti Sharma, Amy Jones, Gary Mueller, Rachel Janney, Jennifer Taylor-Cousar, Mary Cross, Jordana Hoppe, James Cahill, Zubin Mukadam, Jill Finto, Karen Schultz, Silvia Delgado Villalta, Alexa Smith, Susan Millard, Thomas Symington, Gavin Graff, Diane Kitch, Don Sanders, Misty Thompson, Tahuanty Pena, Mary Teresi, Jennifer Gafford, David Schaeffer, Joel Mermis, Lawrence Scott, Hugo Escobar, Kristen Williams, Dana Dorman, Brian O'Sullivan, Ryan Bethay, Zoran Danov, Kat Turbeville, Jimmy Johannes, Angelica Rodriguez, Bridget Marra, Robert Zanni, Ronald Morton, Terri Simeon, Andrew Braun, Nicole Dondlinger, Julie Biller, Erin Hubertz, Nicholas Antos, Laura Roth, Joanne Billings, Catherine Larson, Priya Balaji, John McNamara, Tammy Clark, Rebecca Griffith, Nancy Martinez, Sabiha Hussain, Halina Malveaux, Marie Egan, Catalina Guzman, Joan DeCelie-Germana, Susan Galvin, Adrienne Savant, Nicole Falgout, Patricia Walker, Teresa Demarco, Emily DiMango, Maria Ycaza, Julie Ballo, Pornchai Tirakitsoontorn, Daniel Layish, Desiree Serr, Floyd Livingston, Sherry Wooldridge, Carlos Milla, Jacquelyn Spano, Rebecca Davis, Okan Elidemir, Subramanyam Chittivelu, Ashley Scott, Sarah Alam, Daniel Dorgan, Matt Butoryak, Daniel Weiner, Harmony Renna, Colby Wyatt, Brendan Klein, Anne Stone, Meg Lessard, Michael S. Schechter, Barbara Johnson, Steven Scofield, Theodore Liou, Jane Vroom, Kathryn Akong, Marissa Gil, Legna Betancourt, Jonathan Singer, Ngoc Ly, Courtney Moreno, Moira Aitken, Teresa Gambol, Ronald Gibson, Allison Lambert, Joan Milton, Sarah Smith, Deanna Green, Diana Hodge, Christopher Fortner, Mary Forell, Rachel Karlnoski, Kapil Patel, Cori Daines, Elizabeth Ryan, Rodolfo Amaro-Galvez, Elizabeth Dohanich, Alison Lennox, Zachary Messer, Holly Hanes, Kay Powell, and Deepika Polineni
- Subjects
Pulmonary and Respiratory Medicine - Abstract
Reducing treatment burden is a priority for people with cystic fibrosis, whose health has benefited from using new modulators that substantially increase CFTR protein function. The SIMPLIFY study aimed to assess the effects of discontinuing nebulised hypertonic saline or dornase alfa in individuals using the CFTR modulator elexacaftor plus tezacaftor plus ivacaftor (ETI).The SIMPLIFY study included two parallel, multicentre, open-label, randomised, controlled, non-inferiority trials at 80 participating clinics across the USA in the Cystic Fibrosis Therapeutics Development Network. We included individuals with cystic fibrosis aged 12-17 years with percent predicted FEVFrom Aug 25, 2020, to May 25, 2022, a total of 672 unique participants were screened for eligibility for one or both trials, resulting in 847 total random assignments across both trials with 594 unique participants. 370 participants were randomly assigned in the hypertonic saline trial and 477 in the dornase alfa trial. Participants across both trials had an average ppFEVIn individuals with cystic fibrosis on ETI with relatively well preserved pulmonary function, discontinuing daily hypertonic saline or dornase alfa for 6 weeks did not result in clinically meaningful differences in pulmonary function when compared with continuing treatment.
- Published
- 2023
29. Food Allergen Immunotherapy in Preschool Children: Do We Have the Evidence?
- Author
-
Paxton Loke, Brian P. Vickery, Stacie M. Jones, Rachel L. Peters, Graham Roberts, and Jennifer J. Koplin
- Subjects
Immunology and Allergy - Published
- 2023
30. X–Ka Band Epitaxial ScAlN/AlN/NbN/SiC High-Overtone Bulk Acoustic Resonators
- Author
-
Vikrant J. Gokhale, Matthew T. Hardy, D. Scott Katzer, and Brian P. Downey
- Subjects
Electrical and Electronic Engineering ,Electronic, Optical and Magnetic Materials - Published
- 2023
31. Ultrasound-Guided Enteropexy for Repair of Ostomy Prolapse
- Author
-
Brian P. Fallon, Kevin N. Johnson, Meghan E. Lark, Marcus D. Jarboe, and Matthew W. Ralls
- Subjects
Surgery - Published
- 2023
32. Review of Inquiry in University Mathematics Teaching and Learning: The PLATINUM Project by Gómez-Chacón et al. (2021)
- Author
-
Brian P Katz
- Subjects
Mathematics (miscellaneous) ,Education - Published
- 2023
33. Impact of Age and Sex on Left Ventricular Remodeling in Patients With Aortic Regurgitation
- Author
-
Emmanuel Akintoye, Yoshihito Saijo, Lorenzo Braghieri, Osamah Badwan, Hardik Patel, M Marwan Dabbagh, Joseph El Dahdah, Christine L. Jellis, Milind Y. Desai, L. Leonardo Rodriguez, Richard A. Grimm, Brian P. Griffin, and Zoran B. Popović
- Subjects
Cardiology and Cardiovascular Medicine - Published
- 2023
34. Foreign Minister Tōgō’s Bitter Struggle and the Acceptance of the Potsdam Declaration
- Author
-
Tōgō Kazuhiko and Brian P. Walsh
- Subjects
Cultural Studies ,History ,Sociology and Political Science ,Political Science and International Relations - Abstract
Japan’s decision to accept the terms of the Potsdam Declaration was one of the most pivotal events in the country’s modern history. Most students of the decision-making process agree that Foreign Minister Tōgō Shigenori was the principal motive force supporting acceptance of the Allies’ demands throughout the debate over the action. Some recent historiography in Japan has questioned Tōgō’s approach, focusing particularly on his decision to seek the mediation of the Soviet Union and on the question of why he did not bring hostilities to an end sooner. Historical materials that were previously unavailable to scholars shed some light on these questions. In combination with Tōgō’s daily planner (in the author’s possession), his memoirs, and the author’s own recollection of anecdotes his parents told to him, these materials make possible a detailed examination of Tōgō’s thoughts and actions in the days leading to the acceptance of the Potsdam Declaration. This shows that Tōgō, facing stubborn resistance from the military and from public opinion, nevertheless persevered in his quest to bring the war to an end. He also maintained the trust and respect of not only Emperor Hirohito, but also of Army Minister Anami Korechika, his principal antagonist in the debate.
- Published
- 2023
35. TIC 219006972: a compact, coplanar quadruple star system consisting of two eclipsing binaries with an outer period of 168 d
- Author
-
Veselin B Kostov, Tamás Borkovits, Saul A Rappaport, Brian P Powell, András Pál, Thomas L Jacobs, Robert Gagliano, Martti H Kristiansen, Daryll M LaCourse, Maxwell Moe, Mark Omohundro, Allan R Schmitt, Hans M Schwengeler, Ivan A Terentev, and Andrew Vanderburg
- Subjects
Astrophysics - Solar and Stellar Astrophysics ,Space and Planetary Science ,FOS: Physical sciences ,Astronomy and Astrophysics ,Solar and Stellar Astrophysics (astro-ph.SR) - Abstract
We present the discovery of a new highly compact quadruple star system, TIC 219006972, consisting of two eclipsing binary stars with orbital periods of 8.3 days and 13.7 days, and an outer orbital period of only 168 days. This period is a full factor of 2 shorter than the quadruple with the shortest outer period reported previously, VW LMi, where the two binary components orbit each other every 355 days. The target was observed by TESS in Full-Frame Images in sectors 14-16, 21-23, 41, 48 and 49, and produced two sets of primary and secondary eclipses. These show strongly non-linear eclipse timing variations (ETVs) with an amplitude of $\sim$0.1 days, where the ETVs of the primary and secondary eclipses, and of the two binaries are all largely positively correlated. This highlights the strong dynamical interactions between the two binaries and confirms the compact quadruple configuration of TIC 219006972. The two eclipsing binaries are nearly circular whereas the quadruple system has an outer eccentricity of about 0.25. The entire system is nearly edge-on, with a mutual orbital inclination between the two eclipsing binary star systems of about 1 degree., 16 pages, 13 figures, 4 tables, MNRAS accepted
- Published
- 2023
36. The combination of the enhanced liver fibrosis and FIB‐4 scores to determine significant fibrosis in patients with nonalcoholic fatty liver disease
- Author
-
Zobair M. Younossi, Maria Stepanova, Sean Felix, Thomas Jeffers, Elena Younossi, Zachary Goodman, Andrei Racila, Brian P. Lam, and Linda Henry
- Subjects
Hepatology ,Gastroenterology ,Pharmacology (medical) - Published
- 2023
37. Athlete activism and attendance behavior in the National Football League
- Author
-
Nicholas M. Watanabe, Grace Yan, and Brian P. Soebbing
- Subjects
Strategy and Management ,Tourism, Leisure and Hospitality Management - Published
- 2023
38. Stretching Peptides to Generate Small Molecule β-Strand Mimics
- Author
-
Zoë C. Adams, Anthony P. Silvestri, Sorina Chiorean, Dillon T. Flood, Brian P. Balo, Yifan Shi, Matthew Holcomb, Shawn I. Walsh, Colleen A. Maillie, Gregory K. Pierens, Stefano Forli, K. Johan Rosengren, and Philip E. Dawson
- Subjects
General Chemical Engineering ,General Chemistry - Published
- 2023
39. Environmental <scp>DNA</scp> survey of the Winter Salmonosphere in the Gulf of Alaska
- Author
-
Christoph M. Deeg, Shaorong Li, Svetlana Esenkulova, Brian P. V. Hunt, Angela D. Schulze, and Kristina M. Miller
- Subjects
Ecology ,Genetics ,Ecology, Evolution, Behavior and Systematics - Published
- 2023
40. Cellulite Pathophysiology and Psychosocial Implications
- Author
-
Lawrence S. Bass, Brian P. Hibler, Saami Khalifian, Sachin M. Shridharani, Olga M. Klibanov, and Amir Moradi
- Subjects
Surgery ,Dermatology ,General Medicine - Published
- 2023
41. A cryptic natural variant allele of BYPASS2 suppresses the bypass1 mutant phenotype
- Author
-
Alexander J Cummins, C J Siler, Jacob M Olson, Amanpreet Kaur, Adam K Hamdani, L Kate Olson, Brian P Dilkes, and Leslie E Sieburth
- Subjects
Physiology ,Genetics ,Plant Science - Abstract
The Arabidopsis (Arabidopsis thaliana) BYPASS1 (BPS1) gene encodes a protein with no functionally characterized domains, and loss-of-function mutants (e.g. bps1-2 in Col-0) present a severe growth arrest phenotype that is evoked by a root-derived graft-transmissible small molecule that we call dalekin. The root-to-shoot nature of dalekin signaling suggests it could be an endogenous signaling molecule. Here, we report a natural variant screen that allowed us to identify enhancers and suppressors of the bps1-2 mutant phenotype (in Col-0). We identified a strong semi-dominant suppressor in the Apost-1 accession that largely restored shoot development in bps1 and yet continued to overproduce dalekin. Using bulked segregant analysis and allele-specific transgenic complementation, we showed that the suppressor is the Apost-1 allele of a BPS1 paralog, BYPASS2 (BPS2). BPS2 is one of four members of the BPS gene family in Arabidopsis, and phylogenetic analysis demonstrated that the BPS family is conserved in land plants and the four Arabidopsis paralogs are retained duplicates from whole genome duplications. The strong conservation of BPS1 and paralogous proteins throughout land plants, and the similar functions of paralogs in Arabidopsis, suggests that dalekin signaling might be retained across land plants.
- Published
- 2023
42. Lipid metabolism in dopaminergic neurons influences light entrainment
- Author
-
Regina F. Fernandez, Emily S. Wilson, Victoria Diaz, Jonatan Martínez‐Gardeazabal, Rachel Foguth, Jason R. Cannon, Shelley N. Jackson, Brian P. Hermann, Jeffrey B. Eells, and Jessica M. Ellis
- Subjects
Cellular and Molecular Neuroscience ,Biochemistry - Published
- 2023
43. A practical risk calculator for suicidal behavior among transitioning U.S. Army soldiers: results from the Study to Assess Risk and Resilience in Servicemembers-Longitudinal Study (STARRS-LS)
- Author
-
Jaclyn C. Kearns, Emily R. Edwards, Erin P. Finley, Joseph C. Geraci, Sarah M. Gildea, Marianne Goodman, Irving Hwang, Chris J. Kennedy, Andrew J. King, Alex Luedtke, Brian P. Marx, Maria V. Petukhova, Nancy A. Sampson, Richard W. Seim, Ian H. Stanley, Murray B. Stein, Robert J. Ursano, and Ronald C. Kessler
- Subjects
Psychiatry and Mental health ,Applied Psychology - Abstract
Background Risk of suicide-related behaviors is elevated among military personnel transitioning to civilian life. An earlier report showed that high-risk U.S. Army soldiers could be identified shortly before this transition with a machine learning model that included predictors from administrative systems, self-report surveys, and geospatial data. Based on this result, a Veterans Affairs and Army initiative was launched to evaluate a suicide-prevention intervention for high-risk transitioning soldiers. To make targeting practical, though, a streamlined model and risk calculator were needed that used only a short series of self-report survey questions. Methods We revised the original model in a sample of n = 8335 observations from the Study to Assess Risk and Resilience in Servicemembers-Longitudinal Study (STARRS-LS) who participated in one of three Army STARRS 2011–2014 baseline surveys while in service and in one or more subsequent panel surveys (LS1: 2016–2018, LS2: 2018–2019) after leaving service. We trained ensemble machine learning models with constrained numbers of item-level survey predictors in a 70% training sample. The outcome was self-reported post-transition suicide attempts (SA). The models were validated in the 30% test sample. Results Twelve-month post-transition SA prevalence was 1.0% (s.e. = 0.1). The best constrained model, with only 17 predictors, had a test sample ROC-AUC of 0.85 (s.e. = 0.03). The 10–30% of respondents with the highest predicted risk included 44.9–92.5% of 12-month SAs. Conclusions An accurate SA risk calculator based on a short self-report survey can target transitioning soldiers shortly before leaving service for intervention to prevent post-transition SA.
- Published
- 2023
44. Cellulite: Current Treatments, New Technology, and Clinical Management
- Author
-
Brenda LaTowsky, Carolyn Jacob, Brian P. Hibler, Paul Z. Lorenc, Chrysi Petraki, and Melanie Palm
- Subjects
Surgery ,Dermatology ,General Medicine - Published
- 2023
45. The problem with overreliance on the PCL–5 as a measure of PTSD diagnostic status
- Author
-
Michelle J. Bovin and Brian P. Marx
- Subjects
Clinical Psychology - Published
- 2023
46. Mid-term survivorship of primary total knee arthroplasty with a specific implant
- Author
-
Elizabeth B. Gausden, Simarjeet Puri, Yu-fen Chiu, Mark P. Figgie, Thomas P. Sculco, Geoffrey Westrich, Peter K. Sculco, and Brian P. Chalmers
- Subjects
Orthopedics and Sports Medicine ,Surgery - Abstract
AimsThe purpose of this study was to assess mid-term survivorship following primary total knee arthroplasty (TKA) with Optetrak Logic components and identify the most common revision indications at a single institution.MethodsWe identified a retrospective cohort of 7,941 Optetrak primary TKAs performed from January 2010 to December 2018. We reviewed the intraoperative findings of 369 TKAs that required revision TKA from January 2010 to December 2021 and the details of the revision implants used. Kaplan-Meier analysis was used to determine survivorship. Cox regression analysis was used to examine the impact of patient variables and year of implantation on survival time.ResultsThe estimated survivorship free of all-cause revision was 98% (95% confidence interval (CI) 97% to 98%), 95% (95% CI 95% to 96%), and 86% (95% CI 83% to 88%) at two, five, and ten years, respectively. In 209/369 revisions there was a consistent constellation of findings with varying severity that included polyethylene wear and associated synovitis, osteolysis, and component loosening. This failure mode, which we refer to as aseptic mechanical failure, was the most common revision indication. The mean time from primary TKA to revision for aseptic mechanical failure was five years (5 months to 11 years).ConclusionIn this series of nearly 8,000 primary TKAs performed with a specific implant, we identified a lower-than-expected mid-term survivorship and a high number of revisions with a unique presentation. This study, along with the recent recall of the implant, confirms the need for frequent monitoring of patients with Optetrak TKAs given the incidence of polyethylene failure, osteolysis, and component loosening.Cite this article: Bone Joint J 2023;105-B(3):277–283.
- Published
- 2023
47. Microbial Motility at the Bottom of North America: Digital Holographic Microscopy and Genomic Motility Signatures in Badwater Spring, Death Valley National Park
- Author
-
Carl Snyder, Jakob P. Centlivre, Shrikant Bhute, Gözde Shipman, Ariel D. Friel, Tomeu Viver, Marike Palmer, Konstantinos T. Konstantinidis, Henry J. Sun, Ramon Rossello-Mora, Jay Nadeau, and Brian P. Hedlund
- Subjects
Space and Planetary Science ,Agricultural and Biological Sciences (miscellaneous) - Published
- 2023
48. Prognostic impact of left ventricular systolic dysfunction in patients with mixed aortic valve disease undergoing aortic valve replacement
- Author
-
Yoshihito Saijo, Tom Kai Ming Wang, Nicolas Isaza, Julijana Z. Conic, Douglas Johnston, Eric E. Roselli, Milind Y. Desai, Richard A. Grimm, Lars G. Svensson, Samir R. Kapadia, Brian P. Griffin, and Zoran B. Popović
- Subjects
Radiology, Nuclear Medicine and imaging ,Cardiology and Cardiovascular Medicine - Published
- 2023
49. If You Rebuild It, Will They Come? The Impact of Renovated Sports Facilities on Total Revenue and Attendance
- Author
-
Brian P. Soebbing, Chad S. Seifried, and Patrick Tutka
- Subjects
Organizational Behavior and Human Resource Management ,General Decision Sciences ,Physical Therapy, Sports Therapy and Rehabilitation ,Orthopedics and Sports Medicine - Abstract
The novelty effect has a long history in sport facility research with most research examining new facility construction. The present study explores the impact of renovated facilities, specifically the novelty effect, as it pertains to revenue and secondarily attendance. Within, we also explore four different renovation types as classified by the U.S. National Registry of Historic Places to look at any individual impact or revelation using institutions participating in the National Collegiate Athletic Association Division I Football Bowl Subdivision. Results from ordinary least squares and Tobit estimations from a sample period covering 1993 through 2017 conclude a novelty effect associated with renovations does exist for attendance. However, the effect is shorter in duration and delayed by a few seasons based upon the type of renovation. As for revenues, we find some positive impact on revenues. Those impacts are delayed are on based on certain types of renovation.
- Published
- 2023
50. The Imperial Nation: Ruling Citizens and Subjects in the British, French, Spanish, and American Empires
- Author
-
Brian P. Owensby
- Subjects
History - Published
- 2023
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.